Scientists induce, relieve depression symptoms in mice with light
December 12, 2012 in Neuroscience
Among those who suffer from depression, the dual inabilities to experience enjoyment in things once pleasurable and to physically motivate oneself—to meet challenges, or even to get out of bed in the morning—have been documented for decades, though it has been mysterious why these very different kinds of symptoms show up together, and also disappear together when depression is successfully treated. It has been suspected that the brain chemical dopamine could be a key player in the illness. And yet, in the long history of the study of depression, no one has been able to clearly tie these key concepts together, until now.
Researchers at Stanford University have successfully induced and relieved depression-like deficiencies in both pleasure and motivation in mice by controlling just a single area of the brain known as the ventral tegmental area. It is the first time that well-defined types of neurons within a specific brain region have been directly tied to the control of myriad symptoms of major depressive illness.
In the paper to be published in Nature on Dec. 12, Stanford bioengineer Karl Deisseroth, MD, PhD, and a team including postdoctoral scholars Kay Tye, PhD, and Melissa Warden, PhD, and research assistant Julie Mirzabekov have used a technique known as optogenetics to pinpoint a specific brain location that produces multiple depression-like symptoms. The region in question is the ventral tegmental area, or VTA, a source of dopamine and a central player in the brain's internal motivation and reward systems.
"We have for the first time directly tied dopamine neurons in the VTA to controlling and relieving these very different and diverse symptoms," said Deisseroth, the study's senior author and a professor of bioengineering and of psychiatry and behavioral sciences. "While depression is a complex disease with still many unknowns, this knowledge may help launch new kinds of investigation into the pathways of depression in the brain, and develop concepts to help people suffering from depression."
Deisseroth's team was able to both induce and relieve multiple depression-like symptoms in laboratory mice by genetically modifying the dopamine neurons in the VTA to be sensitive to light. Using fiber optic cables inserted in rodents' brains, they could then instantaneously produce and inhibit the depression-like symptoms by turning the light on and off. This research technique, developed by Deisseroth at Stanford in 2005, is known as optogenetics.
The team examined mice in a depressed-like, low-motivation state induced by mild stressors whose VTA neurons had been optogenetically modified. "When given light stimulation to the VTA dopamine neurons, these mice showed a robust increase in escape-related behavior. They immediately tried harder to get out of challenging situations—reversing back to normal levels of effort from the depressed-like state they were in," explained Deisseroth.
Similarly, he said, when offered the choice of sugar water over plain, the mice that had been in a depressed-like state chose the sugar water with much greater frequency when their VTA dopamine neurons were stimulated by illumination. They opted to experience pleasure—back to normal levels. Finally, and remarkably, Deisseroth noted, optogenetically inhibiting the VTA dopamine neurons instead of stimulating them caused, rather than corrected, both kinds of depression symptoms—instantaneously and reversibly.
"These results directly implicated a single class of neuron in a single brain region—ventral tegmental dopamine neurons—in both producing and relieving very different depression-related symptoms, addressing a mystery in disease pathophysiology," said Deisseroth.
And yet, another key question still remained: What are the VTA dopamine neurons doing to downstream circuits? In other words, how are the depression-related control signals read out? To answer these questions, the researchers next took the work a step further by mapping the effects of dopamine neuron activity in the VTA on the nucleus accumbens, a brain center thought to influence diverse functions of pleasure, and likely the site of action for addictive drugs as well as natural rewards. Seeing a change in the nucleus accumbens would provide information on the mechanism for how VTA dopamine neuron effects are manifested in the brain.
"Indeed, we established that electrophysiological representation of action in the nucleus accumbens is in fact fundamentally altered by VTA dopamine neuron activation. If we activate the VTA dopamine neurons, it influences the nucleus accumbens' encoding of physical, motivated action," emphasized Deisseroth. Together, these results represented a long-sought circuit-level insight into the causes and nature of depression-related behavior.
While the results are significant, Deisseroth, who is also a practicing psychiatrist, cautioned that depression and other mental illnesses are complex, multidimensional and vary from patient to patient. The symptoms of depression are certainly influenced by many neural circuits, he said.
"Nonetheless, the VTA dopamine circuitry we studied is very similar in both rodents and humans. And we have shown that the neurons in this circuit specifically cause, correct and encode diverse symptoms of depression. This is a significant advance in our understanding of the biological underpinnings of depression and related behaviors, with promising implications for future research," said Deisseroth.
More information: DOI: 10.1038/nature11740
Related: DOI: 10.1038/nature11713
Journal reference:
Nature
Provided by
Stanford University Medical Center
-
Morphine and cocaine affect reward sensation differently
Oct 05, 2012 |
not rated yet |
0
-
Study shines light on brain mechanism that controls reward enjoyment
Mar 21, 2012 |
not rated yet |
0
-
Using rabies virus, researcher tracks inputs to dopamine neurons
Jun 06, 2012 |
not rated yet |
0
-
Optogenetics illuminates pathways of motivation through brain, study shows
Nov 18, 2012 |
not rated yet |
0
-
Fat hormone influences baseline dopamine levels and our motivation to eat
Aug 05, 2009 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
-
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013
-
Alcohol and acetaminophen
May 13, 2013
-
Marie Curie's leukemia
May 13, 2013
- More from Physics Forums - Medical Sciences
More news stories
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or ...
Neuroscience
May 18, 2013 |
5 / 5 (1) |
0
|
Temporal processing in the olfactory system
The neural machinery underlying our olfactory sense continues to be an enigma for neuroscience. A recent review in Neuron seeks to expand traditional ideas about how neurons in the olfactory bulb might encode information about ...
Neuroscience
May 17, 2013 |
4 / 5 (1) |
0
|
Melon focus headband turns to Kickstarter for rollout plans
(Medical Xpress)—What if the quality of your work depends more on your focus on the piano keys or canvas or laptop than your musical or painting or computing skills? If target users can be convinced, they ...
Neuroscience
May 17, 2013 |
3.7 / 5 (3) |
0
|
Deep brain stimulation: A fix when the drugs don't work
Neurological disorders can have a devastating impact on the lives of sufferers and their families.
Neuroscience
May 17, 2013 |
5 / 5 (1) |
0
|
Brain makes call on which ear is used for cell phone
If you're a left-brain thinker, chances are you use your right hand to hold your cell phone up to your right ear, according to a newly published study from Henry Ford Hospital in Detroit.
Neuroscience
May 16, 2013 |
2 / 5 (2) |
0
|
Alzheimer's leaves bilingual victims stranded in Canada
The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.
'Gap' for HIV vaccine efforts after latest setback
The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.
Consuming coffee linked to lower risk of detrimental liver disease, study finds
Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...
Ketamine shows significant therapeutic benefit in people with treatment-resistant depression
Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...
Research examines new methods for managing digestive health
Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.
New smartphone application improves colonoscopy preparation
The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...
Dec 12, 2012
Rank: 5 / 5 (1)